Figure 5: Effects of CK or Rh1 alone or in combination on cell activation in HSCs.
From: Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats
(a) HSC-T6 cells were cultured in the presence of Rosiglitazone (RSG), CK, Rh1 or the combination of CK and Rh1 for 6 hours. Cells were then subjected to immunostaining for α-SMA. Original magnification ×400. (b) Quantitative analysis of the relative expression is shown. Data are the mean ± SD of three independent experiments. *P < 0.05 versus control group. (c) Total RNA was extracted and subjected to real-time PCR. All results are normalized to the levels of β-actin and are the means ± SD of three experiments. *P < 0.05 versus control group.
